Brought to you by 
Xoma licenses antibody production technology to Biosite
27 Jul 1999
Executive Summary
Xoma Ltd. has licensed nonexclusive rights to its cell expression technology to Biosite Diagnostics Inc. for both diagnostic products as well as phage display selection of antibody-related protein products.
Deal Industry
- In Vitro Diagnostics
- Pharmaceuticals
-
Biotechnology
- Large Molecule
-
Large Molecule
- Antibodies
Deal Status
- Final
Deal Type
-
Alliance
- Intra-Biotech Deal
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Xoma licenses antibody production technology to Biosite
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice